Dendritic cell vaccine strategy may improve breast cancer treatment outcomes

Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor 2-positive, estrogen receptor-negative (HER2-positive, ER-negative) breast cancer and has shown encouraging results in a recent pilot study.
š Full Story

Arkansas Trooper Does Pit Manever at 136 MPH! Police Chase Ends in Tragedy š¤£
- Assassin's Creed Shadows review: An ambitious and captivating world that's stuck in the past - Kris Holt
- COVID shots protect kids from long COVIDāand donāt cause sudden death - Beth Mole
- 2000s Buddy Comedy Flop Streaming For Free Ready For Rediscovery - Robert Scucci
- Time Is Running Out to Claim $1 Billion in Expiring Tax Refunds
- YRKKH Written Update 11 August 2024: Abhira Refuses to Marry Arman as Ruhiās Plan Unfolds! - Aaradhana Chaurasia
- Streamer Plex raises subscription price for the first time in a decade - Sarah Perez

The Most Futuristic Tech Of 2025.....
- Mythica open sources tools from Sprocket Games and Unleashed games for game development - Dean Takahashi
- Scoring system helps predict risk of developing cancer from common blood disorder in older adults
- A comprehensive list of 2025 tech layoffs - Cody Corrall, Alyssa Stringer, Kate Park
- Beyond RAG: SEARCH-R1 integrates search engines directly into reasoning models - Ben Dickson
- The 9 Types of Migraines: Symptoms and How To Identify Them - Janelle McSwiggin, MSN, RN
- 10 Diabetic-Friendly Breakfast Ideas for Blood Sugar Balance - DevineƩ Lingo, M.S., RDN